Ikarian Capital »

Longboard Pharmaceuticals In shares owned by Ikarian Capital

Quarter-by-quarter ownership of Longboard Pharmaceuticals In (LBPH) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Longboard Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Longboard Pharmaceuticals In held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Longboard Pharmaceuticals In by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $5.9M 980k 6.03
2023-09-30 $2.9M 514k 5.56
2023-06-30 $3.7M 504k 7.34

More positions owned by Ikarian Capital

Argenx Se Sponsored Adr (ARGX)
Krystal Biotech Call Option (KRYS)
Cytokinetics Com New (CYTK)
Alnylam Pharmaceuticals Call Option (ALNY)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Crispr Therapeutics Namen Akt (CRSP)
Eli Lilly & Co. Put Option (LLY)
Sarepta Therapeutics (SRPT)
Prothena Corp SHS Call Option (PRTA)
Amylyx Pharmaceuticals (AMLX)
Nuvalent Inc-a (NUVL)
Immunovant (IMVT)
Crinetics Pharmaceuticals In (CRNX)
Soleno Therapeutics (SLNO)
Eyepoint Pharmaceuticals Com New (EYPT)

View all positions for Ikarian Capital

Top funds holding Longboard Pharmaceuticals In

Cormorant Asset Management
T. Rowe Price Associates
Ikarian Capital
Point72 Asset Management
Vanguard Group
Jpmorgan Chase & Co
Jennison Associates
TD Asset Management
Schonfeld Strategic Advisors
Bank of New York Mellon
Charles Schwab Investment Management
Walleye Trading Advisors
Dimensional Fund Advisors
Jacobs Levy Equity Management
Laurion Capital Management

View all funds holding Longboard Pharmaceuticals In